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The dopaminergic system has been known to be involved in the process of 
sensorimotor gating and correspondingly pre-pulse inhibition (PPI). Disruption of the 
dopamine (DA) system causes deficits in PPI and these deficits in PPI reveal symptoms 
for many psychotic disorders. Likewise, cocaine induces a sharp increase of dopamine 
transmission that alters sensorimotor gating and decreases PPI responses (Geyer and 
Braff, 1987). Adenosine is one system that is associated with the sleep-wake cycle and 
most importantly in regulating neuronal activity. Thus, more and more evidence is 
pointing to its involvement in DA release. The current study set out to examine the role 
of adenosine in cocaine-induced PPI deficits. More specifically, acoustic startle responses 
were examined following cocaine, caffeine (a non-selective adenosine antagonist), and 
the combination of these two stimulants were used to measure PPI. The results of 
administering cocaine and caffeine simultaneously showed a dose-dependent 
neuroprotection of the cocaine-induced decrease in PPI. Thus, the data indicates an 
important role of adenosine in regulating DA transmission. In addition, sex differences 
were examined. Females showed sensitive responses to cocaine-induced PPI compared to 
males. Many studies show that sensitivity to cocaine reward varies during the estrus cycle 
(Kippin et al., 2005, Feltenstein et al., 2009, Zakharova et al., 2009). We observed that 
cocaine produced direct estrus cycle changes. Thus, these changes in estrus cycle may be 
the underlying cause of the sex differences in acoustic startle response for cocaine-
administered animals. Overall, we propose that the blocking abilities of caffeine at 
specific doses suggests a strong interaction between DA and the adenosine system and 
may provide future treatment for psychotic disorders as these treatments may balance 
malfunctioning DA neural circuits. 
 
Keywords: brain, acoustic startle response, PPI, caffeine, cocaine, adenosine, dopamine, 
sensorimotor gating, neuroprotection, nucleus accumbens, schizophrenia, 
psychostimulants, sex differences 
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Introduction: 
 
Sensorimotor gating that occurs in the auditory neural circuit of the brain filters 
attention and response processing. This ability to precisely filter different stimuli allows 
the animal to adapt to non-threatening situations and it allows the inhibition of 
overstimulation of sensory stimuli (Geyer and Braff, 1987). Therefore, deficits in 
sensorimotor gating can lead to sensory overload and consequently cognitive disarray.  
A valuable behavioral model to evaluate sensorimotor gating is the acoustic 
startle response (ASR). The ASR is provoked by sudden auditory stimuli and is 
composed of facial, neck, and limb muscle movement/twitches (Landis and Hunt, 1939).  
The process of “gating” different stimuli is reflected by the magnitude in which the reflex 
response is suppressed by a weaker prestimulus, also termed prepulse inhibition (PPI; 
(Graham, 1975)). PPI is used as a cross-species measure for examining processing 
deficits. Increased dopamine (DA) transmission has been shown to induce changes in 
PPI, as seen with the reduction of PPI after administration of DA agonists to rats 
(Swerdlow et al., 1986, Mansbach et al., 1988) or humans (Morton et al., 1995, 
Abduljawad et al., 1997, Hutchinson et al., 1997).  Thus, DA is highly important in this 
sensory processing. 
There are two different pathways involved in sensorimotor gating of the ASR. 
One is the simple response with the startle stimulus and the other is the auditory non-
startle prepulse where PPI is achieved (Fendt et al., 2001). The midbrain was found to be 
important in this pathway because lesions to this area caused PPI deficits whereas lesions 
to other areas did not. The startling stimulus is processed through the cochlear nuclei that 
projects onto the caudal pontine reticular nucleus (PnC). The PnC is involved in 
movement and projects through interneurons and motorneurons to induce the startle 
response.  
The non-startling tactile input is received through the cochlear nuclei as well but 
projects onto the inferior colliculus (IC) that relays the prepulse for PPI to the superior 
colliculus (SC). The IC is activated by the prepulse and elicits inhibitory mechanisms in 
the PPI response. The SC is a multi-modal processor where all external stimuli converge. 
These regions are essential because lesion studies to the IC (Leitner and Cohen, 1985) or  
SC (Meredith et al., 1992) caused PPI disruptions. The SC then mediates the auditory 
prepulse to the pedunculopontine tegmental nucleus (PPTg) and the laterodorsal 
tegmental nucleus (LDTg). The PPTg is involved in arousal and locomotion and the 
LDTg mediates prolonged attention or alerting responses.  
The PPTg and LDTg receive modulatory input from the forebrain that associates 
the prepulse with the loud stimulus. This association is important in sensorimotor gating 
and psychosis disorders. The nucleus accumbens (Nac) and substantia nigra project onto 
the PPTg, LDTg, and PnC. These specific regions are highly DA dependent and involved 
in motivation and movement. The PPTg and LDTg then converge with the simple 
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response onto the PnC through cholinergic and GABAergic inputs to induce the startle 
response. Lesions to PPTg and LDTg caused significant PPI deficits indicating its crucial 
role (Leitner et al., 1981). Overall, the slow inhibitory pathway of the non-startling 
stimulus mediates the fast excitatory pathway of the startle stimulus to facilitate PPI. It is 
necessary that the occurrence of the prepulse is 20-500ms before the startling stimulus in 
order to achieve PPI. 
Overactivity of the mesolimbic DA system and thus, disruptions in sensorimotor 
gating, are common in psychotic disorders. One such disorder that is characterized by a 
loss of PPI is schizophrenia (Perry and Braff, 1994, Braff et al., 1995). Schizophrenia 
involves an overabundance of DA transmission and difficulties in information 
processing. Patients have high vulnerability to stimuli inundation and cognitive problems. 
They cannot “gate” between extraneous thoughts or prevent sensory stimuli from 
invading their consciousness (Swerdlow et al., 1992). Therefore, sensorimotor gating is 
severely interrupted in schizophrenia and PPI responses are used to diagnose processing 
complications in patients.  
Through its role as an indirect DA agonist, cocaine mimics a schizophrenic 
phenotype (Martinez et al., 1999a, Nunes and Broderick, 2007). Cocaine causes the 
euphoric increase of DA by inhibiting DA transporters (Koob GF, 1997). Therefore, there 
is an excess of DA in the mesolimbic system, the same system where sensorimotor 
deficits occur in schizophrenia. Cocaine has a linear dose-response curve, thus, higher 
doeses produce greater responses. Previous rodent studies showed that cocaine-induced 
deficits in PPI were caused by the activation of DA 1 receptors (D1R) and DA 2 
receptors (D2R), and were reversed with the pretreatment of selective D1R and D2R 
antagonists (Doherty et al., 2008).  
Given the highly addictive properties of cocaine, mechanisms to better understand 
cocaine abuse are being intensively examined. Animal studies have shown that 
pharmacologically altering adenosine aids in the locomotor, reinforcing, and sensitizing 
properties of cocaine (Bedingfield et al., 1998, Kuzmin et al., 2000, Filip et al., 2006, 
Marcellino et al., 2007). Adenosine antagonists facilitated self-administration of cocaine 
while agonists inhibited initiation at specific doses (Knapp et al., 2001). Thus, there are 
observed interactions between adenosine and dopamine that regulate behavior (Wang et 
al., 2003).   
Adenosine is a ubiquitous purine molecule that plays a key modulatory role in 
both dorsal and ventral dopaminergic transmission (Daly, 1993, Fredholm et al., 1999). 
Adenosine has been shown to decrease neural activity. Inhibition of the release of 
excitatory neurotransmitters is potentiated by adenosine compared to any other inhibitory 
neurotransmitters. This results in decreased calcium entry and decreased cAMP 
formation (Fredholm and Dunwiddie, 1988). One substance that targets the adenosine 
system is coffee with the active ingredient of caffeine.  
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Caffeine is a psychostimulant that promotes wakefulness and increases 
locomotion by non-selectively antagonizing the adenosine A1 receptors (A1R) and A2A 
receptors (A2AR;(Lazarus et al., 2011)). There is a high prevalence of caffeine intake in 
schizophrenic patients making it a target of interest for potential treatment (Hughes et al., 
1998, Lara, 2010). Caffeine has hydrophobic properties and easily passes the blood brain 
barrier. A1R are found throughout the brain but primarily in the hippocampus, cerebral 
cortex, NAc and caudate-putamen (Fredholm et al., 1999). A2AR are localized primarily 
in the striatum. The NAc, where both receptor types are located, is the DA dense brain 
area involved in reward and corresponds to motor response. Similarly, cocaine is strongly 
associated with the NAc. Therefore, the NAc is an important region of interest.  
Previous findings showed that A1R’s were co-expressed and formed heteromers 
with D1R, as well as A2AR with D2R (Ongini and Fredholm, 1996, Ferré et al., 2007a). 
Adenosine regulates DA by acting both presynaptically, on A1R to inhibit DA release, 
and postsynaptically, on A2AR by decreasing DA transmission and receptor 
susceptibility. A1R are mostly on glutamate and dopamine terminals, whereas, A2AR are 
concentrated on inhibitory GABAergic striatal neurons (Hettinger et al., 2001, Rosin et 
al., 2003). Thus, inhibiting adenosine facilitates DA release, increases turnover rates, and 
augments DA receptor stimulation (Fernstrom and Fernstrom, 1984, Bickford et al., 
1985, Fredholm and Jonzon, 1988, Hadfield and Milio, 1989). 
Importantly, caffeine-induced increase in locomotion and DA release is highly 
dose-dependent (Solinas et al., 2002, Karcz-Kubicha et al., 2003). Caffeine exhibits an 
inverted “U-shape” dose response curve with peak DA release and locomotor responses 
at 30mg/kg. The lowest dose that produced a weak response was 3mg/kg of caffeine. This 
same weak response was seen at the highest dose of 100mg/kg caffeine. Thus, at these 
low and high doses, caffeine does not elicit an increase in DA release nor its 
corresponding behavioral response. Previous studies have shown that other mechanisms 
of action are also at play at these doses, such as inhibition of phosphodiesterase and 
release of intracellular calcium (Daly, 1993, Ongini and Fredholm, 1996, Fredholm et al., 
1999). 
Previous studies in our laboratory directly examined DA release in the NAc 
following cocaine, caffeine and combination of cocaine and caffeine (Broderick et al., 
2008, Malave and Broderick, 2014). Neuromolecular imaging data were measured using 
the BRODERICK PROBE® biosensor. Procedures and specificities are described 
previously (Broderick, 1988, 1989a, b, 1995, 1999, Broderick et al., 2008). Cocaine 
increased DA release linearly with dose, whereas, caffeine exhibited the inverted “U-
Shape” curve (Broderick et al., 2007, Nesbitt et al., 2008). Combinations of cocaine and 
caffeine revealed a neuroprotection of the surge of DA release induced by cocaine. 
Importantly, this effect was dose-specific. Caffeine did not block cocaine-induced DA 
release at middle doses (25 mg/kg and 5 mg/kg, respectively) but was seen at high (50 
mg/kg and 10 mg/kg, respectively) and low doses (12.5 mg/kg and 2.5 mg/kg, 
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respectively). Furthermore, 8-cyclopentyltheophylline (CPT; 4.8mg/kg), an adenosine A1 
antagonist showed neuroprotection of cocaine (5mg/kg)-induced DA release, suggesting 
a direct role of A1R’s in the regulating actions of cocaine (Broderick et al., 2007). CPT 
also exhibits an inverted “U-shape” dose response curve as caffeine but has peak activity 
at lower doses of 4.8mg/kg (Karcz-Kubicha et al., 2003). 
Based on these neurochemical results, the current study set out to investigate the 
behavioral effects engendered by the combination of caffeine and cocaine using the ASR 
paradigm and its potential implications in the therapy for psychosis disorders. Cocaine 
alters sensorimotor gating because the increased DA causes inaccurate filtering between 
the different magnitudes of startle. Consequently, responses are similar between startles 
with a prepulse and startles without a prepulse, thereby, lowering PPI (Martinez et al., 
1999b). On the other hand, caffeine does not alter PPI in previous human (Flaten and 
Elden, 1999, Swerdlow et al., 2000) or animal (Bakshi et al., 1995) studies.  
Additionally, we examined the effects of sex on PPI responses following cocaine 
and caffeine administration. Females have shown increased vulnerability and respond to 
lower doses of cocaine compared to males (Quinones-Jenab et al., 2001, Quinones-Jenab 
and Jenab, 2012). In laboratory animals, females self-administer cocaine more rapidly, 
become dependent earlier, and relapse faster. Sex hormones, such as estrogen and 
progesterone, may be the underlying cause. The level of sex hormones fluctuates 
throughout the four stages of the estrus cycle, which alters sensitivity to cocaine (Roberts 
et al., 1989). Human studies showed higher cocaine response during the luteal phase 
(moderate estrogen and high progesterone levels) and not the follicular phase (low 
estrogen and progesterone levels) (Evans et al., 2002, Evans, 2007). Throughout the 
estrus cycle in rats, the highest estrogen levels are during the proestrus phase and drops 
during the estrus and diestrus phase (Carter, 1993). Additionally, ovariectomy (OVX) 
procedures significantly diminished these sex differences. 
There is an abundance of research on the influence of sex hormones on cocaine 
addiction. Laboratory animals with higher estrogen levels were shown to have higher 
sensitivity to cocaine (Sircar and Kim, 1999, Becker and Hu, 2008, Quinones-Jenab and 
Jenab, 2012). Estradiol studies have shown an increase in the locomotor and motivational 
aspect of cocaine addiction (Roberts et al., 1989, Kippin et al., 2005). OVX rats treated 
with estradiol and progesterone had greater sensitivity to cocaine than OVX rats treated 
with progesterone alone or with vehicle (Sircar and Kim, 1999, Sell et al., 2000). On the 
other hand, progesterone attenuates cocaine effects by either blocking estrogen or 
counteracting the rewarding effects of cocaine (Jackson et al., 2006). Thus, the most 
assumed theory is that estrogen is essential in the reinforcement of cocaine. However, 
there are still conflicting results in the literature. Some report cocaine responses are 
increased during estrus phase (Hecht et al., 1999, Quiñones-Jenab et al., 1999), had the 
most self-administration during proestrus phase (Feltenstein and See, 2007), or exhibited 
no differences between the estrus or proestrus phase (Sell et al., 2000, Walker et al., 
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2001). One explanation for this is that different hormones may be associated with 
different aspects of cocaine addiction, some affecting locomotion, while others altering 
motivation. The current study examined the interaction between cocaine and estrogen in 
sensorimotor gating. 
We hypothesize that PPI results will reflect the observed DA release in our 
previous studies, that is, caffeine will neuroprotect against the cocaine-induced decrease 
of PPI in a dose dependent manner. We also hypothesize that PPI results for females 






Adult male and female Sprague-Dawley rats (rattus norvegicus), 2 months of age, 
weight matched for sex, were purchased from Charles River Laboratories, North 
Carolina, USA. Animals were housed in the Animal Care Facility under the auspices of 
the City College Institutional Animal Care and Use Committee (IACUC) in compliance 
with National Institute of Health (NIH) guidelines. Food (Purina Rat Chow) and water 
was available ad libitum. Males were housed separately from females in airtight 
seclusion, three or two per chamber.  
 
Drugs and doses: 
Studies were performed in three groups: Cocaine, Caffeine, or combination of 
cocaine and caffeine with low, middle and high doses. Each group had a sample size of 8. 
Within the three groups each animal received each dose as a within-subject control. The 
different doses were given at least 48 hours after the previous one to eliminate residual 
drug effects. Doses were given as described in table 1 in pseudo-random order. Solutions 
for cocaine HCl (Sigma-Aldrich, St. Louis, MO) and caffeine (Sigma-Aldrich, St. Louis, 
MO) were dissolved in distilled water and injected intraperitoneally (i.p). Saline (0.9% 
NaCl) solution was used as a control. Doses were chosen based on peak effects from the 
literature (Solinas et al., 2002, Karcz-Kubicha et al., 2003, Solinas et al., 2005) and 
previous NMI experiments done in this laboratory to correlate behavior with 






LD: 2.5 mg/kg  
MD: 5 mg/kg 
HD: 10 mg/kg 
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Caffeine (n=8) 
Saline 
LD: 12.5 mg/kg 
MD: 25 mg/kg 




LD: 2.5 mg/kg coc & 12.5 mg/kg caff 
MD: 5 mg/kg coc & 25 mg/kg caff 
HD: 10 mg/kg coc & 50 mg/kg caff 
Table 1: Doses administered i.p. immediately before the injection trial. Coc=cocaine; 




The acoustic startle chamber is an SR-LABTM model (San Diego Instruments, San 
Diego, CA) that is automated to record the startle response of small animals. The 
chamber consists of a cylindrical enclosure on a plexiglass base. A speaker is mounted 
24cm above the animal, which provides the background noise, pre-pulse stimuli and 
startle stimuli in random order controlled by the SR-LABTM software. Whole body startle 
responses were recorded 200ms after the presentation of the stimulus. The startle 
responses were then transduced by a piezoelectric accelerometer mounted on a seismic 
sensor plate platform, located below the cylinder in which the animal is placed. The 
subject’s movement generates an electrical current in the sensor that distinguishes 
voluntary movement from startle movement. The sensor detects the pressure pushed 
down by the animal on the platform due to the eliciting stimulus. The chambers were 
designed to minimize extraneous noise and vibrations to attenuate influences from 
external stimuli.   
Startle response to auditory stimuli via muscle movements transduced electrically 
was studied by PPI. Data were recorded as potential in voltage and were concatenated for 
compatibility with Excel software. Vmax was used in calculations denoted by the highest 
voltage during the response window (i.e. the “peak” of the response). %PPI was 
calculated using the formula: %PPI=100-[[mean PPI Vmax/mean startle only Vmax] 
x100]. The 25 sessions in each of the trials (11 minute intervals per trial) consisted of 5 
types of acoustic stimuli delineated in table 2. 
Type No Stimulus Prepulse Pulse 
1. 75 decibels (broadband) - - 
2. - - 120 decibels 
3. - 95 decibels 120 decibels 
4. - 105 decibels 120 decibels 
5. - 115 decibels 120 decibels 
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Table 2: Different magnitudes of acoustic stimuli throughout each trial, some with 
prepulse and some without.75 decibels was the lowest stimuli and 120 was considered the 
startle stimuli. 
 
These types of sessions were randomly placed throughout the trial but each trial 
used the same format in terms of the arrangement of the sessions.  
The ASR paradigm consisted of three trials: habituation, injection and post 1-
hour. The habituation trial was preceded by a 5-minute acclimation period followed by an 
11-minute test period. The habituation trial involved the simplest form of learning that 
conditions the animal to not respond to the pre-pulse stimulus. Pre-pulses were low-
intensity stimuli used to decrease the magnitude of the startle-provoking stimulus 
response. The injection trial was preceded by acute injection of a specific dose of 
cocaine, caffeine or physiological saline relative to body weight and lasted 22 minutes 
(two 11-minute periods were averaged because no significant difference between them). 
The post 1-hour trial measured the lingering effect of the injected drug or saline 1 hour 
after administration and lasted 11 minutes. Animals were returned to their cage after the 
Injection trial was completed and until the Post-1 hour trial started.  
 
Vaginal Smears: 
Samples were collected pre- and post- the injection trial. Females were swabbed 
with a saline soaked cotton tip and dotted on a microscope slide. Samples were observed 
at 40x objective lenses. The vaginal smears were stained with a Diff staining kit (IMEB 
INC, San Marcos, CA) and analyzed according to four stages: proestrus, estrus, metestrus 
and diestrus (Marcondes et al., 2002). Samples were assessed based on the proportions of 
the type of cells to determine the appropriate stages. There were three types of cells: 
round nucleated epithelial cells, irregular shaped anucleated cornified cells and little 
round leukocyte cells. Proestrus phase had prominently epithelial cells. Estrus phase had 
cornified cells. Metestrus phase had an equal amount of all three cells. Finally, the 
diestrus phase consisted of predominantly leukocytes.  
 
Statistics: 
Repeated measures Analysis of Variance (ANOVA) as studied by the Statistica 
6.0 Software program (Tulsa, OK) was used to determine statistically significant 
differences in behavioral responses after administration of drug(s) within and between 
sex, trial, drug and dose. Fisher post hoc tests performed pairwise statistical analyses 
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Female ASR 
An overall 3-way Repeated Measures ANOVA analysis was used for the 
following results (Fig. 1-3). This ANOVA showed drug (F (2,83)=11.9, p=0.00003), dose 
(F (3,83)=13.2, p<0.00001), drug x dose (F (6,83)=5.2, p=0.00015), trial (F (2,166)=28.2, 
p<0.00001), trial x drug (F (4,166)=5.9, p=0.000178), and trial x dose (F (6,166)=3.5, 
p=0.00264) effects. 
 
Female cocaine ASR 
There were no changes in %PPI following saline injection or post 1 hour trials 
(Fig. 1). On the other hand, females decreased %PPI response after cocaine 
administration, regardless of dose. A Fisher pairwise post hoc test revealed significant 
decrease in %PPI between the cocaine group from the habituation trial to the injection 
trial for the LD (p=0.00001), MD (p=0.00001), and HD (p=0.00001) groups. During the 
injection trial, cocaine decreased %PPI compared to the saline group for the LD 
(p=0.001), MD (p=0.00001), and HD (p=0.00001) groups. Within the dose groups, HD 
had significantly lower %PPI compared to the LD group during the injection trial 
(p=0.0304). During the post 1-hour trial, the LD (p=0.0432), MD (p=0.00001), and HD 
(p=0.00001) groups had significantly lower %PPI than the saline group. Additionally 
during the post 1-hour trial, the LD (p=0.0302), MD (p=0.00001), and HD (p=0.00001) 
groups were significantly lower compared to their corresponding habituation trial. The 
LD group had significantly higher %PPI compared to the MD (p=0.0255) and HD 
(p=0.0123) groups during the post 1-hour trial. Both LD (p=0.0166) and HD (p=0.0303) 
groups increased %PPI from the injection trial to the post 1-hour trial but were still lower 
than the habituation trial.  
 
Female Caffeine ASR 
 After caffeine administration %PPI remained relatively stable from the 
habituation trial to the injection trial (Fig. 2). After post 1-hour, %PPI was significantly 
reduced for both LD (p=0.0465) and MD (p=0.0199) compared to saline. The LD group 
significantly decreased %PPI from the habituation to the post 1-hour trial (p=0.0221). 
The MD group had lower PPI responses compared to the HD group during the post 1-
hour trial (p=0.0274). Across drugs, LD (p=0.0060), MD (p=0.0010) and HD 
(p=0.00001) groups had significantly lower %PPI for the cocaine group compared to the 
caffeine group during the injection trial. Cocaine HD group had significantly reduced 
%PPI compared to caffeine HD group during the post 1-hour trial (p=0.00001).  
 
Female combination ASR 
There were no changes in %PPI following administration of both LD and HD 
cocaine and caffeine across all trials (Fig. 3). The MD combination group had reduced 
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%PPI compared to saline (p=0.00001), LD (p=0.00001), and HD (p=0.00001) groups 
during the injection trial. The MD combination group had significantly lower %PPI 
during injection trial compared to habituation (p=0.00001) and post 1-hour (p=0.0031) 
trials. During the injection trial, the MD combination group had significantly lower PPI 
responses compared to the MD caffeine group (p=0.0002). Importantly, cocaine LD and 
HD groups had significantly reduced %PPI compared to combination LD (p=0.0008) and 
HD (p=0.00001) groups following the injection trial. PPI responses were significantly 
reduced in the post 1-hour trial for the cocaine HD group compared to the combination 
HD group (p=0.0010).  
 
Male ASR Data 
An overall 3-way Repeated Measures ANOVA analysis was used to examine the 
male data (Fig. 4-6). There were drug (F (2,85)=13.6, p=0.00007), dose (F (3,85)=8.7, 
p<0.00004), drug x dose (F (6,85)=5.2, p=0.00013), trial (F (2,170)=58, p<0.00001), trial 
x drug (F (4,170)=23.7, p<0.00001), trial x dose (F (6,170)=9.8, p<0.00001), and trial x 
drug x dose (F (12,170)=7.2, p<0.00001) effects. 
 
Male cocaine ASR: 
There were no significant changes in %PPI following saline administration for all 
trials (Fig. 4). During the injection trial, there were no changes in PPI responses for the 
LD or MD groups but %PPI decreased for the HD group compared to the habituation trial 
(p=0.0054). Male PPI responses following the LD of cocaine caused decreased PPI 
(p=0.0081), however, this was to a lower degree than females. During the post 1 hour 
trial, both MD and HD groups showed lower %PPI in a dose-dependent manner and 
showed significance to the habituation (MD: p=0.00001; HD: p=0.00001) and the 
injection (MD: p=0.00001; HD: p=0.00001) trials and to the saline group within the post 
1-hour trial (MD: p=0.00001; HD: p=0.00001). The HD group during post 1-hour trial 
was significantly lower in PPI responses compared to both the LD (p=0.00001) and the 
MD (p=0.00001) groups.  
 
Male caffeine ASR: 
There were no differences in the male caffeine group following all trials despite 
drug or dose (Fig. 5).  
 
Male combination ASR: 
The LD or HD groups did not differ in PPI responses throughout the trials (Fig. 
6). On the other hand, the MD group showed decreased %PPI following the injection trial 
compared to the saline (p=0.00001), LD (p=0.00001), HD (p=0.00001) groups and to the 
habituation trial (p=0.00001). The same was seen during the post 1-hour trial compared 
to the saline (p=0.0011), LD (p=0.0039), HD (p=0.0421) groups and to the habituation 
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trial (p=0.0001). Across drugs, MD combination group had significantly lower PPI 
responses compared to cocaine (p=0.00001) and caffeine (p=0.00001) MD groups during 
the injection trial. The combination MD group had lower %PPI compared to the caffeine 
MD group (p=0.0035) during the post 1-hour trial, while, it had higher %PPI compared to 
the cocaine MD group (p=0.0005). Importantly, the combination HD group had 
significantly higher PPI responses compared to the cocaine HD group during the post 1-
hour trial (p=0.00001).  
 
Male vs. Female ASR data: 
An overall 4-way Repeated Measures ANOVA analysis was used to examine the 
female data compared to the male data (Fig. 1-6). There were sex (F(1,168)=34.3 , 
p=0.00001), sex x dose (F(3,168)=3.3 , p=0.0215), trial x sex (F(2,336)=9.2 , 
p=0.00013),  trial x sex x drug (F(4,336)=13.7 , p=0.00001),  trial x sex x dose 
(F(6,336)=3.1 , p=0.0057),  and trial x sex x drug x dose (F(12,336)=2.0 , p=0.0235). 
During the injection trial following cocaine, females had significantly lower PPI 
responses compared to the male LD (p=0.00001), MD (p=0.00001) and HD (p=0.00001) 
groups (Fig. 1,4). During the post 1-hour trial, the male cocaine HD group had lower 
%PPI than the female group (p=0.00001). Within the caffeine groups, males had higher 
PPI responses than females during the post 1-hour trial for the LD (p=0.0172) and MD 
(p=0.0047) groups (Fig. 2,5). During the combination doses and throughout the trials, 
females and males exhibited similar behavior and did not significantly differ in PPI 
responses (Fig. 3,6).  
 
Estrus cycle data 
Female Vaginal Smears 
Vaginal smears were assessed using a microscope and scored based on cells 
described in the methods section (Fig. 7a-h). For all doses of cocaine, female smears 
showed differences in estrus cycle phase between pre- and post-injection trials. Cocaine 
induced seemingly-random changes in the estrus cycle (Fig. 7 c-d). This was not seen 
following caffeine administration (Fig. 7e-f). Furthermore, combination of cocaine and 
caffeine did not alter the estrus cycle (Fig. 7g-h). The cocaine-induced changes were 
blocked by caffeine. 
 
Female PPI vs. changes in estrus cycle correlations: 
There was a negative correlation between PPI responses and number of changes 
in the estrus cycle, i.e. the more changes in the estrus cycle induced by cocaine the lower 
PPI responses (Fig. 8a,b). Past studies have shown that behavioral responses to cocaine 
are related to estrogen levels. On the other hand, we did not find a specific trend in one 
precise phase but in the number of phase fluctuations. There was no correlations between 
the lowest PPI response and highest estrogen levels (proestrus phase). Instead, cocaine 
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induced such changes that the post-injection smear was in 3 phases different from the 
pre-injection smear. The order of phases went as follows: proestrus-estrus-metestrus-
diestrus. Thus, if the pre-injection smear was in estrus phase and the post-injection smear 
was in proestrus phase, the number of phase jumps was 3. This negative relationship was 
seen greater after the injection trial (R(30)=0.58466, p<0.00044) compared to the post 1-
hour trial (R(30)=0.45312, p<0.00920), suggesting a time sensitive correlation based on 
the pharmacokinetics of cocaine. It is important to note that vaginal smears were only 
collected after the injection trial not the post 1-hour trial. Therefore, scores in Fig. 10b are 





Figure 1: Female ASR data following cocaine administration, %PPI response decreased 
dose-dependently. Saline injection did not alter %PPI for all three trials. 1-hour after 
injection, %PPI increased for the LD and HD groups but did not reach the saline group 
levels. MD group remained relatively stable between injection trial and post-1 hour trial. 
Significance was denoted by p<0.05. LD= low dose; 2.5mg/kg, MD= middle dose; 
5mg/kg, and HD= high dose; 10mg/kg. *: significant to saline group and habituation trial; 
**: significant to saline group, LD group, and habituation trial; ^: significant to respectful 
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Figure 2: Female ASR data following various doses of caffeine administration, %PPI did 
not significantly change. Post 1-hour trial had significantly lower %PPI for the LD and 
MD groups from the saline group. The HD group did not. Significance was denoted by 
p<0.05. LD= low dose; 12.5mg/kg, MD= middle dose; 25mg/kg, and HD= high dose; 





Figure 3: Combination of both cocaine and caffeine for female ASR data showed no 
differences between saline, LD or HD groups. All groups responded to acoustic startle 
the same way. However, the MD group significantly decreased %PPI during the injection 
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2.5mg/kg cocaine and 12.5mg/kg caffeine, MD= middle dose; 5mg/kg cocaine and 
25mg/kg caffeine, and HD= high dose; 10mg/kg cocaine and 50mg/kg caffeine. ^: 
significant to cocaine group; *: significant to habituation trial, post injection trial, saline 
group, LD group, HD group, and respectful caffeine group.  
 
 
Figure 4: Following cocaine administration, PPI responses for males did not differ, 
however, post 1-hour %PPI response decreased dose-dependently.  Saline injection did 
not alter %PPI for all three trials. Also, the LD group did not affect PPI as seen with 
females. Significance was denoted by p<0.05. LD= low dose 2.5mg/kg, MD= middle 
dose 5mg/kg, and HD= high dose 10mg/kg. *: significant to habituation trial; **: 
significant to habituation trial, injection trial, saline group, LD group, and respectful 
caffeine group; ***: significant to habituation trial, injection trial, saline group, LD 
group, MD group, and respectful caffeine and combination groups; ^: significant to 
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Figure 5: Male ASR data following various doses of caffeine administration, %PPI did 
not significantly change throughout the three trials. LD= low dose; 12.5mg/kg, MD= 
middle dose; 25mg/kg, and HD= high dose; 50mg/kg. 
 
 
Figure 6: Throughout the three trials combination of both cocaine and caffeine for male 
ASR data showed no differences between saline, LD or HD groups. However, the MD 
group significantly decreased PPI responses during the injection trial and then increased 
slightly during the post 1-hour trial. Significance was denoted by p<0.05. LD= low dose; 
2.5mg/kg cocaine and 12.5mg/kg caffeine, MD= middle dose; 5mg/kg cocaine and 
25mg/kg caffeine, and HD= high dose; 10mg/kg cocaine and 50mg/kg caffeine. *: 
significant to habituation trial, saline group, LD group, and HD group; **: significant to 
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7 a, b 
Pre-Saline              Post-Saline 
       
  Proestrus    à    Proestrus 
7 c, d 
Pre-2.5 mg/kg Cocaine        Post-2.5 mg/kg Cocaine 
           
  Estrus    à    Metestrus 
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Fig 7 a-h: Studies on the estrus cycle in females show that cocaine induces changes in 
the estrus cycle that is not seen with caffeine, combination of cocaine and caffeine or 
saline. These changes are even expressed at the low dose as seen above.   
 
7 e, f  
Pre-12.5 mg/kg Caffeine               Post-12.5 mg/kg Caffeine  
           
  Proestrus    à                Proestrus 
7 g, h 
Pre-2.5/12.5 combo        Post- 2.5/12.5 combo 
            
  Metestrus           à        Metestrus 
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Fig. 8a: ASR responses were correlated with number of estrus cycle phase changes 
following the cocaine injection trial. Cocaine induced randomized changes in the estrus 
cycle that were correlated to their %PPI scores. There was an indirect relationship 
between the number of phase changes to PPI responses, i.e. if the animal’s estrus cycle 
jumped from estrus to proestrus the phase change would be “3”. The order of phases in 
the estrus cycle went from proestrus-estrus-metestrus-diestrus. R value= 0.58466.  
 
 
Fig. 8b: ASR responses were correlated as described in Fig. 8a, but for the cocaine post 
1-hour trial. There is a negative correlation. Correlation was not as strong during the post 
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Discussion: 
 
 The major findings of this study are 1) females showed exacerbated PPI 
responses, that is deficits in sensorimotor gating, to cocaine compared to males, 2) 
caffeine neuroprotected against cocaine-induced deficits in sensorimotor gating, 
reflecting similar patterns in DA release and estrus cycle changes, 3) this neuroprotection 
was highly dose-dependent at low and high doses, and 4) cocaine caused rapid changes in 
the estrus cycle that was blocked with the combination of caffeine, indicating an 
interaction between estrogen and DA with a regulatory role of adenosine. 
Sensorimotor gating deficit responses were detected at a higher degree for 
females compared to males during the low dose of cocaine. The effects of the low dose of 
cocaine were minimal in the males, whereas, the females showed significant disruption in 
sensorimotor gating. This is consistent with the literature on cocaine sensitivity, 
acquisition, dependence and relapse being stronger in females than males at lower doses 
(Griffin et al., 1989, Becker and Hu, 2008, Quinones-Jenab and Jenab, 2012). Females 
were found to associate cocaine use to contextual cues and conditioned stimuli more so 
than males (Quinones-Jenab and Jenab, 2012).  
There are sex differences observed throughout all stages of drug abuse. Our 
results show that females were more sensitive to the aversive cognitive effects of cocaine. 
Decreased PPI reflects a schizophrenic phenotype, therefore, this may provide insight as 
to why females have different symptoms than males and are more sensitive to cognitive 
disarray (Häfner, 2003). In general, males have a quicker onset than females, however, 
females experience more positive symptoms and males experience more negative 
symptoms (Castle and Murray, 1993, Castle, 1999). Positive symptoms include 
delusions, thought disorder, and hallucinations. These respond well to medication 
because they involve a chemical imbalance in the brain associated with DA. Negative 
symptoms are more behavior and social developmental problems that do not respond well 
to treatment. With schizophrenia, females are more vulnerable to sensorimotor deficits 
than males. Thus, our results indicate greater sensitivity to ASR consistent with female 
psychosis symptoms.  
Corresponding with the literature, cocaine administration produced a linear 
decrease in PPI for the increasing doses. This finding was regardless of sex. However, 
females responded at a faster rate than males for the same dose. In the literature, female 
locomotor responses were double-fold or higher to male response at the same dose and 
lasted longer (Quinones-Jenab and Jenab, 2012). Previous studies in this laboratory on 
the release of DA in the NAc in vivo following low, middle, and high doses of cocaine 
showed this linear effect as well (Broderick et al., 2006, Broderick et al., 2007). 
Additionally, preliminary data in this laboratory showed that females had higher release 
of DA at lower doses compared to males. Thus, males needed a higher dose to reach 
equivalent levels of DA release and locomotor effects as females (Quinones-Jenab and 
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Jenab, 2012). These sex differences were more substantial at lower doses, whereas, the 
gap between sexes decreased with higher doses. Importantly, this increased vulnerability 
to cocaine in females was not caused by the pharmacokinetic differences of cocaine 
between sexes (Evans and Foltin, 2010). Females had similar benzoylecgonine (a cocaine 
metabolite) plasma levels to males, indicating similar metabolism of cocaine. Also, peak 
cocaine plasma levels did not change between different estrus cycle phases. Therefore, 
estrogen did not change the rate of metabolism.  
Since males require higher doses of cocaine to elicit similar biochemical and 
behavioral responses to females, one drawback of this study is that doses did not exceed 
10mg/kg of cocaine. However, previous studies in this laboratory used doses 10-40mg/kg 
of cocaine during the ASR for males and females (Broderick and Rosenbaum, 2013). 
Results showed that both males and females exhibited decreased PPI at these doses and 
were more exacerbated in females. In the current study, males administered 10mg/kg 
started to show a decrease in PPI during the injection trial compared to the habituation 
trial that was not seen during the low or middle dose groups. Thus, higher doses of 
cocaine can produce greater responses earlier in trials and the doses used in this 
experiment were too low to affect sensorimotor gating to a worse degree.  
Alternatively, these sex differences in ASR were abolished following caffeine 
administration. Caffeine is showing more and more clinical relevance, caused by its 
antagonistic effects on adenosine, including protecting against Parkinson’s Disease and 
aiding in stroke (Ross et al., 2000, Rivera-Oliver and Díaz-Ríos, 2014). It is well 
established that caffeine has biphasic properties and is behaviorally active at specific 
doses (Fredholm et al., 1999). Extremely high doses of caffeine show aversive effects. 
The LD50 in rodents for caffeine is 200mg/kg (Eichler, 1976). Caffeine studies must 
adjust for metabolic body weight to accurately compare rodents to humans. For instance, 
10mg/kg of caffeine injected into a rat is equivalent to 250mg for a human weighing 
70kg or 3.5mg/kg dose, roughly 2-3 cups of coffee (Morgan et al., 1982). The route of 
entry is also different; rodents are given i.p. or i.v. injections while humans orally 
consume caffeine periodically throughout the day. However, in this study we were testing 
the immediate response of specific doses of caffeine and their interaction with cocaine.  
Regardless of dose, caffeine did not alter PPI responses for either males or 
females during the injection phase. On the other hand, females started to show a minimal 
decrease in PPI responses post-1 hour after the caffeine injection for the low and middle 
dose groups. This effect was not seen following the high dose. Therefore, caffeine had 
minor residue effects that caused decreased PPI responses for low and middle doses. It 
could be postulated that this decrease is caused by the “crash” associated after caffeine 
intake. More research is needed to determine this effect and to explain why it was not 
seen after the high dose. There is little research on the residual effects of caffeine on ASR 
(Fredholm et al., 1999).   
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Interestingly, cocaine and caffeine studies have shown very dose-specific effects. 
Conditioned place preference (CPP) and drug discrimination studies showed biphasic 
results: increasing effects of cocaine at first and then decreasing effects, that of which 
were reflective of the caffeine dose (Harland et al., 1989, Bedingfield et al., 1998, 
Fredholm et al., 1999). Previous studies in this laboratory found that males following the 
high dose paradigm (10mg/kg cocaine and 50mg/kg caffeine) showed cocaine CPP, 
caffeine CPP aversion, and CPP levels similar to baseline in combination (Nesbitt et al., 
2008). Thus, at the high dose caffeine blocked the CPP abilities of cocaine. Self-
administration studies showed caffeine-induced reinstatement of extinguished cocaine 
seeking behavior. However, doses did not exceed 20mg/kg (Green and Schenk, 2002). 
Indeed, caffeine has been shown to have aversive effects at doses exceeding 30mg/kg 
(Brockwell et al., 1991). Additionally, results from our laboratory showed biochemical 
and behavioral evidence in this dose-specific response of caffeine (Broderick et al., 2008, 
Malave and Broderick, 2014). Based on this we propose that behaviorally active doses of 
caffeine potentiate cocaine’s actions, whereas, low and high doses of caffeine 
neuroprotect.  
In the present results, this neuroprotective behavior (i.e. the reversal of cocaine-
induced PPI deficits after combination with caffeine) was seen at low doses and high 
doses for both males and females. On the other hand, neuroprotection was not seen for 
the middle dose group. These results parallel the previous neuromolecular imaging data 
from this laboratory on DA release. Also, this is consistent with the inverted “U-shaped” 
curve observed with peak caffeine responses at the 30mg/kg dose. There is a synergic 
effect at the peak middle dose of caffeine when combined with cocaine. Low and high 
doses of caffeine were shown to release DA at a lower rate than the middle dose, and thus 
did not contribute to this further disruption in PPI with cocaine but acted to reverse it.  
The lack of neuroprotection at the peak middle dose following combination of 
both cocaine and caffeine could be dependent on the interaction between the two-receptor 
types. Since caffeine is non-selective the activation and the communication of both A1R 
and A2AR may be involved. On GABAergic neurons DA and adenosine receptors form 
heteromers that cross talk and are highly dependent on each other (Ferré et al., 2007a, 
Ferré et al., 2007b). On Glutamatergic neurons, A1R and A2ARs form heteromers and 
indirectly influence DA release (Ciruela et al., 2006). Previous data on A2AR antagonists 
showed the importance of blocking A2AR in the stimulatory effects of caffeine (Ledent 
et al., 1997, El Yacoubi et al., 2000), and that A1R inhibition potentiated A2AR effects 
(Karcz-Kubicha et al., 2003). Without blocking A1R, the stimulatory effects of A2AR 
antagonists were lower, indicating an important role for inhibiting both to induce 
increased stimulatory response (Halldner et al., 2004). Thus, the interaction of both 
receptors may potentiate cocaine’s response leading to the synergistic effect for both DA 
release and PPI deficits observed at the combination middle dose.  
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On the other hand, the neuroprotective behavior of caffeine may be caused by the 
low and high doses activating different receptors. Past studies have found that A1R are 
activated first by caffeine because of their higher affinity (Ferré et al., 2013). Then at 
increasing doses A2AR are activated which consequently decreases A1R activity. 
Therefore, at low doses, A1Rs are predominately active, eliminating the A1R-A2AR 
heteromer stimulatory interaction. Previous data in this laboratory using A1R antagonist, 
CPT, showed the ability of CPT (4.8mg/kg) to decrease DA release of 5mg/kg cocaine 
(Broderick et al., 2006, Malave and Broderick, 2014). Similarly, at high doses of caffeine 
A1Rs have been shown to be predominately involved in the depressant locomotor effects 
of caffeine (El Yacoubi et al., 2000). Thus, A1R selective antagonism may play a crucial 
role in this neuroprotection. Alternatively, interaction with other mechanisms may be the 
underlying cause of neuroprotection seen at the high dose, such as regulation of 
phosphodiesterase and calcium (Daly, 1993, Fredholm et al., 1999). Additional selective 
adenosine antagonists, specifically A2AR, on DA release in combination with cocaine 
and during ASR studies are needed.  
Duration of caffeine exposure can be a factor as well. Acute vs. chronic studies 
using an i.p injection vs. freely drinking access of caffeine showed attenuation in cocaine 
self-administration in chronic caffeine use than in acute low dose use (Kuzmin et al., 
2000). Chronic caffeine drinking increased c-fos and NGFI-A mRNA in the cerebral 
cortex following administration of cocaine. c-fos and NGFI-A are transcription factors 
characterized as immediate early genes (IEG). IEGs are activated in response to first 
round of stimuli at the transcription level and regulate cell growth and differentiation 
signaling. Increased neuronal activity cause increased IEG expression (Fredholm et al., 
1999). Late response genes are activated based on IEGs. Thus, chronic caffeine use 
changed the expression of proteins in the brain that are shown to regulate cocaine use 
(Kuzmin et al., 2000). Additionally, repeated exposure to caffeine was shown to 
eliminate the reinstatement of cocaine extinction that is present during the acute dose 
(Schenk et al., 1996).  
Furthermore, there are beneficial aspects to chronic caffeine use. Long-term use 
was shown to be associated with decreased seizure susceptibility (Von Lubitz et al., 
1993b), decreased ischemic brain damage (Rudolphi et al., 1989) and increased spatial 
learning capacity (Von Lubitz et al., 1993a). Daily caffeine exposure at a low dose could 
cause characteristics similar to an acute high dose of caffeine shown to decrease cocaine-
induced effects. Indeed, IEGs are increased following doses exceeding 50mg/kg of 
caffeine (Svenningsson et al., 1995). Therefore, high doses of caffeine may facilitate 
important adaptive transcriptional or neuropeptide protein expression in the brain 
inducing neuroprotective behavior.  
Expanding on this concept, patients with schizophrenia have increased intake of 
caffeine suggesting a form of self-medication (Hughes et al., 1998, Lara, 2010). Although 
we state that behaviorally active doses of caffeine potentiate cocaine-induced disruption 
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in PPI, this is at an acute dose. Caffeine intake is habitually consumed throughout the day 
with multiple servings on a daily basis. Therefore, the chronic intake of caffeine may aid 
in psychosis symptoms inducing protein expression, via IEGs, protecting against the 
aversive effects of schizophrenia. This is a fairly new concept and more preclinical and 
clinical research is needed.  
The sex differences observed in this study were highly dependent on sex 
hormones. We observed that cocaine induced phase changes in the estrus cycle upon 
injection at all doses, whereas, caffeine did not produce such changes. Interestingly, the 
cycle altering effects of cocaine were blocked in the combination of caffeine and cocaine. 
This pattern of neuroprotection via caffeine was similar to responses in PPI and DA 
release studies suggesting that DA, adenosine, and estrogen strongly interact with each 
other causing increased sensitivity to cocaine that was reversed when the adenosine 
system was antagonized.  
Next, we looked at correlating the PPI responses with the estrus cycle changes. 
Since PPI is DA dependent, we predicted higher levels of estrogen (during proestrus) 
would induce greater PPI deficiencies. However, our correlations did not conclude 
concrete evidence for a specific phase causing the most vulnerability. Instead we found a 
negative relationship between PPI scores and the number of phase changes in the estrus 
cycle. For instance, pre-cocaine injection smears in the estrus phase changing to proestrus 
phase in post-cocaine injection of the same animal would be considered 3 phase jumps 
based on the succession of phases in the cycle: proestrus-estrus-metestrus-diestrus. 
Therefore, the increased sensitivity of sensorimotor gating from cocaine appeared to be 
caused by the change in phase itself and the impact of the fluctuation in hormone levels 
instead of one specific phase. 
Sex differences are seen throughout the stages of drug abuse. Thus, this is a 
complex problem and may have a combination of factors. More studies are needed to 
extensively examine this concept in ASR. Ovariectomy with supplemental hormone 
treatment can help determine exact interactions between PPI responses and sex hormone 
levels. Blood samples can be taken to quantify concentrations of circulating sex 
hormones with ELISA kits in addition to vaginal smears.  
There is another method of analyzing the estrus cycle phase changes. This method 
interestingly reads the electrical resistance of the vaginal mucosa (EC40, Fine Science 
Tools, Foster City, CA). Preliminary data in this laboratory shows a correlation between 
estrus cycle phase and voltage (Nesbitt et al., 2008). Using a volt reader to swab the same 
way as a vaginal smear elicits a voltage that varies between the four estrus phases. The 
preliminary results show that cocaine changes the electrical resistance (kilohm) at low, 
middle, and high doses, whereas, caffeine does not significantly change the electrical 
resistance. Additionally, combination of cocaine with caffeine does not change the 
electrical resistance. The electrical resistance voltage and vaginal smear exfoliate 
cytology show paralleling results and reflect the DA release and PPI results. The volt 
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reader gives a conclusive number immediately after, whereas a vaginal smear is 
subjectively scored. Therefore, the electrical resistance of the vaginal mucosa recording 
is potentially a new tool to better test/evaluate estrus cycle changes. 
 In addition to hormone effects, there may be other factors involved in these sex 
differences (Quinones-Jenab and Jenab, 2012). Differences in signaling caused by 
sexually dimorphic regulation of DA or other neuronal regulators may be the origin of 
these differences. Also, differences caused by the sex chromosomes on the nigrostriatal 
or mesocorticolimbic system could play a role.  
Moreover, there were no changes in the estrus cycle for females following the 
middle dose in combination. However, there were differences in PPI and DA release, 
indicating that these neuroprotective differences were not a result of estrogen levels. 
These differences reflect the male data further proving that estrogen is not involved in the 
behavioral and biochemical differences at the middle dose because it is present for both 
sexes.   
For future studies, the BRODERICK PROBE® biosensor will be placed in the 
NAc imaging DA release in vivo while simultaneously in the ASR paradigm to better 
correlate DA release to behavior. Another important area of interest in the ASR pathway 
is the PnC (Fendt and Koch, 1999). As described earlier the PnC is strongly involved in 
PPI. Therefore, the BRODERICK PROBE® biosensor can detect neurotransmitter activity 
in the PnC as a direct result of cocaine and caffeine activation in the NAc and its effect 
on ASR. 
In conclusion, we propose evidence that disruptions in PPI are directly contingent 
on interactions between DA and the adenosine system, providing a close cause and effect 
relationship between brain and behavior that is strongly dependent on dose to produce 
neuroprotective behavior. Additionally, these results provide insight on sex differences in 
cocaine abuse pointing to the strong interaction between estrogen and DA in concert with 
modulation from the adenosine system. Furthermore, we suggest potential treatment 
options for mental disorders involving the malfunction of the DA circuit via the 
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